Dana Investment Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,345
| Closed | -$273K | – | 531 |
|
|
2024
Q1 | $273K | Sell |
9,345
-1,100
| -11% | -$32.1K | 0.01% | 492 |
|
|
2023
Q4 | $352K | Sell |
10,445
-500
| -5% | -$16.9K | 0.02% | 361 |
|
|
2023
Q3 | $336K | Hold |
10,945
| – | – | 0.02% | 353 |
|
|
2023
Q2 | $439K | Sell |
10,945
-17,880
| -62% | -$716K | 0.02% | 337 |
|
|
2023
Q1 | $1.18M | Sell |
28,825
-950
| -3% | -$38.8K | 0.06% | 215 |
|
|
2022
Q4 | $1.15M | Sell |
29,775
-5,774
| -16% | -$223K | 0.06% | 210 |
|
|
2022
Q3 | $1.89M | Sell |
35,549
-2,358
| -6% | -$125K | 0.11% | 131 |
|
|
2022
Q2 | $2.21M | Buy |
+37,907
| New | +$2.21M | 0.11% | 128 |
|